Kaposi sarcoma

Archives of Pathology and Laboratory Medicine

Volumn 137, Issue 2, 2013, Pages 289-294

  Radu, Oana ^a   Pantanowitz, Liron ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT NUCLEAR ANTIGEN (LNA); NUCLEAR PROTEIN; PHOSPHOPROTEIN;

AIDS RELATED COMPLEX; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; METABOLISM; PROGNOSIS; REVIEW;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; DIAGNOSIS, DIFFERENTIAL; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROGNOSIS; SARCOMA, KAPOSI;

EID: 84874729837     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2012-0101-RS     Document Type: Review

References (30)

1. Kaposi M. Idiopathisces multiples Pigmentsarkom der Haut. Archiv fur Dermatologi und Syphilis. 1872;3: 265-273.
2. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266(5192): 1865-1869.
3. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med. 2000;342(14): 1027-1038.
4. Pantanowitz L, Dezube BJ. Advances in the pathobiology and treatment of Kaposi sarcoma. Curr Opin Oncol. 2004;16(5): 443-449.
5. Pantanowitz L, Stebbing J, Dezube BJ. Overview of Kaposi sarcoma. In: Pantanowitz L, Stebbing J, Dezube BJ, eds. Kaposi Sarcoma: A Model of Oncogenesis. Kerala, India: Research Signpost; 2010: 1-40.
6. Hong YK, Foreman K, Shin JW, et al. Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet. 2004;36(7): 683-685.
7. Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV. Kaposi's sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med. 2007;49(3): 119-138.
8. Pantanowitz L, Moses AV, Dezube BJ. The inflammatory component of Kaposi sarcoma. Exp Mol Pathol. 2009;87(2): 163-165.
9. Pantanowitz L. Kaposi sarcoma: appraisal of therapeutic agents. Cancer. 2008;112(5): 962-965.
10. Sullivan RJ, Pantanowitz L, Casper C, Stebbing J, Dezube BJ. HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis. 2008;47(9): 1209-1215.
11. Pantanowitz L, Dezube BJ. Kaposi's sarcoma: progression, exacerbation and regression. Cancer Res J. 2008;2: 111-121.
12. Pantanowitz L, Dezube BJ. Kaposi sarcoma in unusual locations. BMC Cancer. 2008;8: 190.
13. Krown SE, Metroka C,Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria; AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1989; 7(9): 1201-1207.
14. Ackerman AB. Subtle clues to diagnosis by conventional microscopy: the patch stage of Kaposi's sarcoma. Am J Dermatopathol. 1979;1(2): 165-172.
15. Pantanowitz L, Grayson W, Simonart T, Dezube BJ. Pathology of Kaposi's sarcoma. J HIV Ther. 2009;14(2): 41-47.
16. Grayson W. Recognition of dual or multiple pathology in skin biopsies from patients with HIV/AIDS. Patholog Res Int. 2011;2011: 398546.
17. Pantanowitz L, Dezube BJ, Pinkus GS, Tahan SR. Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma. J Cutan Pathol. 2004;31(1): 26-34.
18. Grayson W, Pantanowitz L. Histological variants of cutaneous Kaposi sarcoma. Diagn Pathol. 2008;3: 31.
19. O'Donnell PJ, Pantanowitz L, Grayson W. Unique histologic variants of cutaneous Kaposi sarcoma. Am J Dermatopathol. 2010;32(3): 244-250.
20. Konstantinopoulos PA, Dezube BJ, Pantanowitz L. Morphologic and immunophenotypic evidence of in-situ Kaposi's sarcoma. BMC Clin Pathol. 2006;6: 7.
21. Craddock KJ, Labonte S, Ghazarian D. Anaplastic Kaposi sarcoma resembling epithelioid angiosarcoma in an HIV-positive man. Eur J Dermatol. 2008;18(3): 358-359.
22. Pantanowitz L, Duke WH. Lymphoedematous variants of Kaposi's sarcoma. J Eur Acad Dermatol Venereol. 2008;22(1): 118-120.
23. Luzar B, Antony F, Ramdial PK, Calonje E. Intravascular Kaposi's sarcoma - a hitherto unrecognised phenomenon. J Cutan Pathol. 2007;34(11): 861-864.
24. Schwartz RA, Spicer MS, Janninger CK, Cohen PJ, Melczer MM, Lambert WC. Keloidal Kaposi's sarcoma: report of three patients. Dermatology. 1994; 189(3): 271-274.
25. Ramdial PK, Sing Y, Naicker S, Calonje E, Sewram V, Singh B. Langerhans cells in anaplastic Kaposi sarcoma withapaucivascular phenotype: a potential diagnostic pitfall. Pathol Int. 2011;61(4): 221-227.
26. Ramdial PK, Sing Y, Subrayan S, et al. Granulomas in acquired immunodeficiency syndrome-associated cutaneous Kaposi sarcoma: evidence forarole for Mycobacterium tuberculosis. J Cutan Pathol. 2010;37(8): 827-834.
27. Pantanowitz L, Otis CN, Dezube BJ. Immunohistochemistry in Kaposi's sarcoma. Clin Exp Dermatol. 2010;35(1): 68-72.
28. Pantanowitz L, Pinkus GS, Dezube BJ, Tahan SR. HHV8 is not limited to Kaposi's sarcoma. Mod Pathol. 2005;18(8): 1148-1150.
29. Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, Di Trolio R, De Placido S, Dezube BJ. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol. 2007;8(2): 167-176.
30. Sullivan RJ, Pantanowitz L. New drug targets in Kaposi sarcoma. Expert Opin Ther Targets. 2010;14(12): 1355-1366.